Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2019
Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid LeukemiaJun Ma, Shoujing Zhao, Xinan Qiao, et al.
Cancers|May 13, 2026
Development and Characterization of a Novel Congenital Acute Erythroid Leukemia Cell Line with Unique FeaturesPrasiksha Sitaula, Manisha Gadgeel, Holly Edwards, et al.
Blood Cancer Journal|June 8, 2021
The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AMLXinan Qiao, Jun Ma, Tristan Knight, et al.
Haematologica|March 2, 2019
Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemiaXinyu Li, Yongwei Su, Gerard Madlambayan, et al.
Scientific Reports|July 5, 2022
Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironmentAdrianne Wallace-Povirk, Lisa Rubinsak, Agnes Malysa, et al.
Cancers|August 28, 2020
Cotargeting of Mitochondrial Complex I and Bcl-2 Shows Antileukemic Activity against Acute Myeloid Leukemia Cells Reliant on Oxidative PhosphorylationFangbing Liu, Hasini A Kalpage, Deying Wang, et al.
Cancer Research|July 26, 2015
Maspin Expression in Prostate Tumor Cells Averts Stemness and Stratifies Drug SensitivityM Margarida Bernardo, Alexander Kaplun, Sijana H Dzinic, et al.
Plos One|April 20, 2019
Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinomaSijana H Dzinic, Zaid Mahdi, M Margarida Bernardo, et al.
Haematologica|March 14, 2020
The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemiaXinyu Li, Yongwei Su, Katie Hege, et al.
ASPET Discovery|July 9, 2026
Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant FLT3- internal tandem duplication acute myeloid leukemiaNibal Eid, Jianlei Zhao, Jenna Thibodeau, et al.
Pageof 3